skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 495  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?
Material Type:
Article
Add to My Research

Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?

Diabetologia, 2024-06, Vol.67 (6), p.974-984 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-024-06100-z

Digital Resources/Online E-Resources

2
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study
Material Type:
Article
Add to My Research

Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study

Diabetologia, 2024-06, Vol.67 (6), p.1029-1039 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-024-06111-w

Digital Resources/Online E-Resources

3
Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium
Material Type:
Article
Add to My Research

Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium

Diabetologia, 2024-06, Vol.67 (6), p.1051-1065 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-024-06090-y

Digital Resources/Online E-Resources

4
Feasibility of prevention of type 2 diabetes in low- and middle-income countries
Material Type:
Article
Add to My Research

Feasibility of prevention of type 2 diabetes in low- and middle-income countries

Diabetologia, 2024-05, Vol.67 (5), p.763-772 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06085-1

Digital Resources/Online E-Resources

5
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease
Material Type:
Article
Add to My Research

Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease

Diabetologia, 2024-05, Vol.67 (5), p.864-873 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06058-4

Digital Resources/Online E-Resources

6
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank
Material Type:
Article
Add to My Research

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank

Diabetologia, 2024-05, Vol.67 (5), p.837-849 [Peer Reviewed Journal]

The Author(s) 2024 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-024-06108-5

Digital Resources/Online E-Resources

7
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study
Material Type:
Article
Add to My Research

Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study

Diabetologia, 2024-03, Vol.67 (3), p.459-469 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06048-6

Digital Resources/Online E-Resources

8
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Material Type:
Article
Add to My Research

Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study

Diabetologia, 2024-03, Vol.67 (3), p.483-493 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06057-5

Digital Resources/Online E-Resources

9
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
Material Type:
Article
Add to My Research

Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia

Diabetologia, 2024, Vol.67 (1), p.19-26 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06041-z

Digital Resources/Online E-Resources

10
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells
Material Type:
Article
Add to My Research

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Diabetologia, 2023-12, Vol.66 (12), p.2346-2355 [Peer Reviewed Journal]

The Author(s) 2023. corrected publication 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06002-6

Digital Resources/Online E-Resources

11
Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
Material Type:
Article
Add to My Research

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Diabetologia, 2023-12, Vol.66 (12), p.2238-2249 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06016-0

Digital Resources/Online E-Resources

12
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
Material Type:
Article
Add to My Research

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy

Diabetologia, 2023-12, Vol.66 (12), p.2307-2319 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-06008-0

Digital Resources/Online E-Resources

13
Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes
Material Type:
Article
Add to My Research

Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

Diabetologia, 2023-11, Vol.66 (11), p.2164-2169 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05990-9

Digital Resources/Online E-Resources

14
Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers
Material Type:
Article
Add to My Research

Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers

Diabetologia, 2023-11, Vol.66 (11), p.2017-2029 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05977-6

Digital Resources/Online E-Resources

15
(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study
Material Type:
Article
Add to My Research

(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study

Diabetologia, 2023-11, Vol.66 (11), p.2030-2041 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05986-5

Digital Resources/Online E-Resources

16
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
Material Type:
Article
Add to My Research

Incretins and cardiovascular disease: to the heart of type 2 diabetes?

Diabetologia, 2023-10, Vol.66 (10), p.1820-1831 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05973-w

Digital Resources/Online E-Resources

17
Socioeconomic aspects of incretin-based therapy
Material Type:
Article
Add to My Research

Socioeconomic aspects of incretin-based therapy

Diabetologia, 2023-10, Vol.66 (10), p.1859-1868 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05962-z

Digital Resources/Online E-Resources

18
Sex differences in type 2 diabetes
Material Type:
Article
Add to My Research

Sex differences in type 2 diabetes

Diabetologia, 2023-06, Vol.66 (6), p.986-1002 [Peer Reviewed Journal]

The Author(s) 2023. corrected publication 2023 ;2023. The Author(s). ;The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023, corrected publication 2023 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-023-05891-x ;PMID: 36897358

Full text available

19
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
Material Type:
Article
Add to My Research

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis

Diabetologia, 2023-04, Vol.66 (4), p.642-656 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-022-05832-0 ;PMID: 36404375

Full text available

20
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
Material Type:
Article
Add to My Research

Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort

Diabetologia, 2023-03, Vol.66 (3), p.482-494 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-022-05826-y ;PMID: 36347992

Full text available

Results 1 - 20 of 495  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1996  (7)
  2. 1996 To 2002  (15)
  3. 2003 To 2009  (82)
  4. 2010 To 2017  (201)
  5. After 2017  (191)
  6. More options open sub menu

Language 

  1. Japanese  (118)
  2. Norwegian  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait